Kromek Group Share Forecast, Price & News

GBX 15.97
-0.18 (-1.11 %)
(As of 04/16/2021 04:02 PM ET)
Today's Range
Now: GBX 15.97
50-Day Range
MA: GBX 16.24
52-Week Range
Now: GBX 15.97
Volume696,158 shs
Average Volume3.29 million shs
Market Capitalization£68.97 million
P/E RatioN/A
Dividend YieldN/A
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection products for medical imaging, nuclear detection, and security screening markets in the United Kingdom, North America, Asia, Europe, and Australasia. Its solutions provide high-resolution information on material composition and structure to enable the identification of cancerous tissues and hazardous materials, as well as for the analysis of radioactive materials. The company also provides a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology, such as handheld rugged gamma detectors, thermal neutron detectors, gamma-ray detector spectrometers, scintillator detectors, preamplifiers for radiation detectors and detector electronics, and EV-CPG compact gamma ray detectors, as well as quant GR1 shielded gamma detectors, multichannel analyzers, CZT-based gamma ray imagers, quant air, scalable x-ray CZR linear array, gamma-ray spectroscopy software, gamma ray radionuclide detectors, and voltage to frequency converters. In addition, it offers medical imaging products, including CZT gamma detector for SPECT imaging, CZT bone mineral densitometry detectors, and photon-counting spectral CT. Further, the company provides security products, such as D3 PRD high accuracy, D3M, and D3S PRD personal radiation detectors; D3S wearable RIID gamma neutron detectors; D3S NET networked radiation detectors and static node; static radiation detector; vehicle mounted radiation detectors; UAV radiation mapping drone and AARM system; liquid explosive detection algorithm; and Identifier liquid explosive detectors. Additionally, it engages in scientific research and development activities. The company sells its products through distributors, OEM, and direct sales. Kromek Group plc was incorporated in 2013 and is headquartered in Sedgefield, the United Kingdom.
Kromek Group logo

Industry, Sector and Symbol

Industry Medical Devices
Year FoundedN/A



Sales & Book Value

Annual Sales£12.36 million
Cash FlowGBX 1.67 per share
Book ValueGBX 12 per share



Market Cap£68.97 million
Next Earnings DateN/A
OptionableNot Optionable


Kromek Share News (KMK)
March 10, 2021 |  lse.co.uk
Kromek Group PLC - Second Price Monitoring Extn
January 9, 2021 |  proactiveinvestors.com.au
Kromek Group PLC - Price Monitoring Extension
January 9, 2021 |  proactiveinvestors.com
Kromek Group PLC
March 29, 2020 |  www.barrons.com
Is Kromek Group (LON:KMK) A Risky Investment?
January 27, 2020 |  finance.yahoo.com
Site visit by International Trade Secretary
January 27, 2020 |  www.lse.co.uk
Is Kromek Group plc's (LON:KMK) CEO Being Overpaid?
October 4, 2019 |  finance.yahoo.com
Is Kromek Group plc's (LON:KMK) CEO Being Overpaid?
October 4, 2019 |  finance.yahoo.com
Kromek Secures Radiation Contracts Worth GBP1.6 Million
September 24, 2019 |  www.morningstar.co.uk
Is Kromek Group (LON:KMK) Weighed On By Its Debt Load?
August 20, 2019 |  finance.yahoo.com
See More Headlines


Overall MarketRank

0.54 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
GBX 15.97
-0.18 (-1.11 %)
(As of 04/16/2021 04:02 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KMK News and Ratings via Email

Sign-up to receive the latest news and ratings for KMK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Kromek Group (LON:KMK) Frequently Asked Questions

What stocks does MarketBeat like better than Kromek Group?

Wall Street analysts have given Kromek Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Kromek Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Kromek Group's earnings last quarter?

Kromek Group plc (LON:KMK) announced its quarterly earnings data on Wednesday, December, 11th. The company reported ($0.70) earnings per share for the quarter.
View Kromek Group's earnings history

How has Kromek Group's stock price been impacted by Coronavirus (COVID-19)?

Kromek Group's stock was trading at GBX 18 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, KMK stock has decreased by 11.3% and is now trading at GBX 15.97.
View which stocks have been most impacted by COVID-19

Who are Kromek Group's key executives?

Kromek Group's management team includes the following people:
  • Dr. Arnab Basu MBE, CEO & Exec. Director (Age 48, Pay $231k)
  • Mr. Paul N. Farquhar, CFO & Director (Age 59)
  • Mr. Albertus Beumer, COO & Exec. Director
  • Mr. Ian Radley, Chief Technical Officer (Age 64)
  • Prof. Brian Keith Tanner MA, DPhil, CPhys, FInstP, FRSA, Advisor (Age 73)
  • Prof. Max Robinson, Advisor (Age 76)

Who are some of Kromek Group's key competitors?

What other stocks do shareholders of Kromek Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kromek Group investors own include Eden Research (EDEN), 544021 (ALK.L) (ALK), Surgical Innovations Group (SUN), Amigo (AMGO), AMETEK (AME), Amur Minerals (AMC), Aminex (AEX), ADiTx Therapeutics (ADTX), Adamis Pharmaceuticals (ADMP) and Acasti Pharma (ACST).

What is Kromek Group's stock symbol?

Kromek Group trades on the London Stock Exchange (LON) under the ticker symbol "KMK."

How do I buy shares of Kromek Group?

Shares of KMK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Kromek Group's stock price today?

One share of KMK stock can currently be purchased for approximately GBX 15.97.

How much money does Kromek Group make?

Kromek Group has a market capitalization of £68.97 million and generates £12.36 million in revenue each year.

How many employees does Kromek Group have?

Kromek Group employs 100 workers across the globe.

What is Kromek Group's official website?

The official website for Kromek Group is www.kromek.com.

Where are Kromek Group's headquarters?

Kromek Group is headquartered at Netpark Incubator, Thomas Wright Way, STOCKTON-ON-TEES, TS21 3FD, United Kingdom.

How can I contact Kromek Group?

Kromek Group's mailing address is Netpark Incubator, Thomas Wright Way, STOCKTON-ON-TEES, TS21 3FD, United Kingdom. The company can be reached via phone at +44-1740-626060.

This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.